Evidence map›Paper›PMID 27821657›Full record

ArticleJournal of medical genetics2017

The UCL low-density lipoprotein receptor gene variant database: pathogenicity update.

Sarah Leigh, Marta Futema, Ros Whittall, Alison Taylor-Beadling, Maggie Williams, Johan T den Dunnen, Steve E Humphries

Abstract read
In one paragraph

Article in Journal of medical genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Statins for children with familial hypercholesterolemia.The Cochrane database of systematic reviews · 2019
    Pooled it
  2. Statins for children with familial hypercholesterolemia.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. International journal of molecular sciences · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Role of non-coding variants in cardiovascular disease.Journal of cellular and molecular medicine · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah LeighCentre for Cardiovascular Genetics, Institute of Cardiovascular Sciences, University College London, London, UK.ORCID 0000-0003-3368-7059
Marta FutemaCentre for Cardiovascular Genetics, Institute of Cardiovascular Sciences, University College London, London, UK.
Ros WhittallCentre for Cardiovascular Genetics, Institute of Cardiovascular Sciences, University College London, London, UK.
Alison Taylor-BeadlingNE Thames Regional Genetics Service, Great Ormond Street Hospital, London, UK.
Maggie WilliamsBristol Genetics Laboratory, Pathology Sciences, Blood Sciences and Bristol Genetics, Southmead Hospital, Bristol, UK.
Johan T den DunnenClinical Genetics and Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Steve E HumphriesCentre for Cardiovascular Genetics, Institute of Cardiovascular Sciences, University College London, London, UK.

Funding

British Heart Foundation RG/08/008/25291
6 · The paper itself

Abstract

backgroundFamilial hypercholesterolaemia (OMIM 143890) is most frequently caused by variations in the low-density lipoprotein receptor (

methodsPubMed searches and alerts were used to identify novel

resultsThe updated database (http://www.lovd.nl/LDLR) now includes 2925 curated variants, representing 1707 independent events. All 129 nonsense variants, 337 small frame-shifting and 117/118 large rearrangements were classified as 4 or 5. Of the 795 missense variants, 115 were in classes 1 and 2, 605 in class 4 and 75 in class 3. 111/181 intronic variants, 4/34 synonymous variants and 14/37 promoter variants were assigned to classes 4 or 5. Overall, 112 (7%) of reported variants were class 3.

conclusionsThis study updates the

Indexed as

Databases, GeneticGenetic VariationHumansHyperlipoproteinemia Type IIMutation, MissensePhenotypePromoter Regions, GeneticReceptors, LDLLDLR protein, humanReceptors, LDLdatabaseFamilial Hypercholesterolemiain silico pathogenicity predictionsLDLRlocus specific variant

Identifiers

PMID27821657
PMCPMC5502305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.